TB Alliance is Honored to Accept the Prix Galien Award for Best Pharmaceutical Agent
NEW YORK (October 30, 2020)—At the Prix Galien Awards Ceremony on Thursday, October 29, The Galien Foundation named pretomanid the
TB Alliance with the Support of the Republic of Korea Announce Initiative to Broaden Adoption and Scale Up of New Treatments for Drug-Resistant Tuberculosis (TB)
LIFT-TB to increase treatment completion rates for drug-resistant TB, focusing on seven high-burden Southeast and Central Asian countries that shoulder
Building Global Capacity for Modern TB Treatment Research
As TB Alliance acknowledges its 20th year, we remain committed to advancing new cures and meeting the aspirations of those
With Progress against TB in Jeopardy, New and Improved Tools Are More Urgent than Ever
NEW YORK (October 14, 2020)—The World Health Organization’s Global Tuberculosis (TB) Report 2020 confirms that efforts to track and treat TB
One Year Since U.S. Approval, Accelerating Access to New TB Therapy
PRETORIA — Today marks the one year anniversary of the US FDA’s approval of pretomanid as part of the BPaL
Dr. Mel Spigelman Named in Fast Company’s Annual List of the Most Creative People in Business
NEW YORK (August 4, 2020)—Fast Company today announced its 11th annual list of the Most Creative People in Business, honoring
TB Alliance Announces European Commission Authorisation of New Treatment for Highly Drug-Resistant Tuberculosis
Pretomanid, developed by the non-profit TB Alliance, has received EU marketing authorisation in combination regimen with bedaquiline and linezolid in
Stepping up to Introduce Child-Friendly TB Medicines
As TB Alliance acknowledges its 20th year, we remain committed to advancing new cures and meeting the aspirations of those
Mylan Secures DCGI Approval in India for Pretomanid, a Treatment for Highly Drug-Resistant Forms of Tuberculosis
Pretomanid is only the third new anti-tuberculosis (TB) drug developed specifically for drug-resistant forms of the disease to be approved
TB Alliance Opposes United States’ Withdrawal from World Health Organization
NEW YORK (July 9, 2020)—TB Alliance supports recent commentaries including those in The Lancet and from the Global Health Council